Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Immunology

• Publication date

  1993-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7508417PMCID PMC1422236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coupling of ligands to liposomes independently of solute entrapment: observations on the formed vesicles.

  1993cited by this paper
• Liposomes in Drug Delivery

  1993cited by this paper
• Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides.

  1992cited by this paper
• Liposomes as carriers of antigens and adjuvants.

  1991cited by this paper
• Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide

  1991cited by this paper
• Universal vaccine carrier. Liposomes that provide T-dependent help to weak antigens.

  1991cited by this paper
• Parameters affecting the immunogenicity of a liposome‐associated synthetic hexapeptide antigen

  1991cited by this paper
• Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes.

  1990cited by this paper
• Defining minimal requirements for antibody production to peptide antigens.

  1990cited by this paper
• Immunological adjuvants: a role for liposomes.

  1990cited by this paper
• Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective.

  1989cited by this paper
• Primary immune response to liposomal tetanus toxoid in mice: the effect of mediators.

  1989cited by this paper
• Mannose-mediated targeted immunoadjuvant action of liposomes.

  1988cited by this paper
• Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen

  1988cited by this paper
• The effect of surface-coupled antigen of liposomes in immunopotentiation.

  1987cited by this paper
• Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants

  1987cited by this paper
• Engineering of immunogenic peptides by co‐linear synthesis of determinants recognized by B and T cells

  1987cited by this paper
• Hepatitis B virus proteins eliciting protective immunity.

  1987cited by this paper
• A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg.

  1987cited by this paper
• Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.

  1987cited by this paper
• A synthetic vaccine constructed by copolymerization of B and T cell determinants

  1987cited by this paper
• Genetic and Molecular Basis for T‐ and B‐Cell Recognition of Hepatitis B Viral Antigens

  1987cited by this paper
• Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics.

  1987cited by this paper
• Bystander help in primary immune responses in vivo

  1986cited by this paper
• Immunological priming with synthetic peptides of foot-and-mouth disease virus.

  1985cited by this paper
• Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus.

  1984cited by this paper
• Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

  1982cited by this paper
• Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.

  1980cited by this paper

• From Olive Oil Emulsions to COVID-19 Vaccines: Liposomes Came First.

  2023cites this paper
• Conjugation of Native-Like HIV-1 Envelope Trimers onto Liposomes Using EDC/Sulfo-NHS Chemistry: Requirements and Limitations

  2020cites this paper
• Liposomes Came First: The Early History of Liposomology.

  2017cites this paper
• Comparing Antibody Responses in Chickens Against Plasmodium falciparum Lactate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase with Freund#’s and Pheroid#® Adjuvants

  2015cites this paper
• Intranasal, Liposome-Adjuvanted Cockroach Allergy Vaccines Made of Refined Major Allergen and Whole-Body Extract of Periplaneta americana

  2013cites this paper
• Accelerated blood clearance of pegylated liposomal topotecan: influence of polyethylene glycol grafting density and animal species.

  2012cites this paper
• HEAT SHOCK PROTEIN MICRO-ENCAPSULATION AS A DOUBLE TOOL FOR THE IMPROVEMENT OF NEW GENERATION VACCINES

  2002cites this paper
• Immunopotentiation of Staphylococcus aureus type 5 capsular polysaccharide co-entrapped in liposomes with alpha-toxin.

  2001cites this paper
• Enhancement of the immune response to hepatitis B virus vaccine by antigen specific IgM.

  2000cites this paper
• Large unilamellar vesicles as trehalose-stabilised vehicles for vaccines: storage time and in vivo studies.

  2000cites this paper
• Immunization with a Peptide Corresponding to Chlamydial Heat Shock Protein 60 Increases the Humoral Immune Response in C3H Mice to a Peptide Representing Variable Domain 4 of the Major Outer Membrane Protein of Chlamydia trachomatis

  1999cites this paper
• Vaccine entrapment in liposomes.

  1999cites this paper
• Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes

  1999cites this paper
• Chapter 3 – Immunization with peptides

  1999cites this paper
• CHAPTER 2.4 – DNA vaccination: A role for liposomes

  1998cites this paper
• Synthesis of Neoglycolipids Containing Oligosaccharides Based on 3,6-Branched-α-D-Mannopyranosides as the Carbohydrate Moieties

  1998cites this paper
• The mode of action of immunological adjuvants.

  1998cites this paper
• “Virosomes”, a new liposome-like vaccine delivery system

  1998cites this paper
• Liposome‐mediated DNA vaccination

  1997cites this paper
• The Role of Cytokines in the Action of Immunological Adjuvants

  1997cites this paper
• Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity.

  1997cites this paper
• Controlled delivery of antigens and adjuvants in vaccine development.

  1996cites this paper
• Generation of human monoclonal antibodies against ganglioside antigens and their applications in the diagnosis and therapy of cancer.

  1996cites this paper
• MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates.

  1996cites this paper
• Structural and Functional Characterization of Liposomal Recombinant Hepatitis B Vaccine

  1996cites this paper
• Liposomes As Immunological Adjuvants and Vaccine Carriers

  1996cites this paper
• Liposomes and ISCOMS as vaccine formulations.

  1995cites this paper
• Genetic Restriction of Responses to Peptide Antigens

  1995cites this paper
• Antigen-specific primary immune response of human B-lymphocytes after in vitro immunization with GM3 ganglioside

  1995cites this paper
• Liposomal presentation of antigens for human vaccines.

  1995cites this paper
• GENETIC RESTRICTION OF RESPONSES TO PEPTIDE ANTIGENS

  1995cites this paper
• The immunological adjuvant and vaccine carrier properties of liposomes.

  1994cites this paper
• Co-Entrapment of T-Cell and B-Cell Peptides in Liposomes Overcomes Genetic Restriction in Mice and Induces Immunological Memory

  1993cites this paper